期刊文献+

超抗原和肿瘤抗原修饰树突状细胞的杀瘤效应 被引量:1

Anti-tumor effect of dendritic cells modified by superantigen and tumor antigen
暂未订购
导出
摘要 目的:测定经超抗原金黄色葡萄球菌肠毒素B(SEB)和结肠癌肿瘤抗原联合修饰树突状细胞(DC)的活性。方法:结肠癌手术标本体外培养出结肠癌细胞并鉴定之,冻融法制备肿瘤抗原;同一患者外周血分离出单个核细胞,以细胞因子诱导为DC;尼龙棉柱过滤获取T淋巴细胞;肿瘤抗原和不同质量浓度的SEB联合修饰DC;以联合抗原修饰后的DC为刺激细胞,自体T淋巴细胞为效应细胞,相同时间下以不同比例共同孵育后,采用MTT法检测对结肠癌细胞的体外杀伤效果。结果:诱导出表达CD11c,CD80,HLA-DR分子的DC,经结肠癌肿瘤抗原和SEB联合修饰后,上述分子表达上调。联合抗原修饰DC的T细胞活化作用强于单独使用结肠癌肿瘤抗原修饰DC的T细胞活化作用。100μg/LSEB和肿瘤抗原联合修饰的DC以1:100比例与T淋巴细胞共孵后的杀伤肿瘤细胞效应最强。结论:SEB和肿瘤抗原联合修饰DC的活性明显强于单用肿瘤抗原修饰DC的活性。 Aim: To study the activity of dendritic cells (DC) induced by staphylococcal enterotoxin B (SEB) and tumor antigen. Methods:The cancer cells from the specimen of a patient with colon carcinoma were cultured and identified. The tumor antigen was prepared by using methods of freezing thawing. DC was obtained from peripheral blood monouclear cells and identified. T lymphocytes were acquired by nylon-fiber column filtering. Then, DC loaded with SEB and tumor antigens was hatched together with T lymphocytes by means of different proportion. The activity of T lymphocyte excited by DC was assayed with MTT method. Results: Induced DC expressed CD11c,CD80 and HLA-DR. Through modification of SEB and tumor antigen, its expression upregulated. Activation of T lymphocyte excited by DC that modified by SEB and tumor antigen was stronger than that excited by DC that modified by only tumor antigen. DC that modified by SEB and tumor antigen hatched together with T lymphocyte with a proportion had the strongest anti-tumor effects. Conclusion : The activity of DC modified by SEB and tumor antigen is stonger than the activity of DC modified only by tumor antigen.
出处 《郑州大学学报(医学版)》 CAS 北大核心 2008年第1期60-62,共3页 Journal of Zhengzhou University(Medical Sciences)
基金 贵州省科技基金资助项目20033040
关键词 金黄色葡萄球菌肠毒素B 树突状细胞 T淋巴细胞 结肠癌 staphylococcal enterotoxin B dendritic cell T lymphocyte colon cancer
  • 相关文献

参考文献8

二级参考文献40

共引文献23

同被引文献18

  • 1薛辛东,杜立中,毛萌,等.儿科学[M].第2版.北京:人民卫生出版社,2010.133-137.
  • 2胡亚美,江载芳.诸福棠实用儿科学[M].第7版.北京:人民卫生出版社,2005:1204-1205.
  • 3Llewelyn M,cohen J. Superantigen:microbial agentgs that corrupt immu- nity[J]. Lancet Infect Dis,2002,2(3): 156-62.
  • 4Alouf JE, Miiller-Alouf H.Staphylococcal and streptococcal superanti- gens: molecular,biological and clinical aspects[J]. Int J Med Microbiol, 2003,292 (7-8) : 429-40.
  • 5Fraser JD,Prof T. The bacterial superantigen and superantigen-like pro- teins[J]. Immunol Rev, 2008,10 (225) : 226-243.
  • 6Arad G,Levy R,Nasie I,et al. Binding of superanting toxins into the CD28 homodimer interface is essential for induction of cytokime genes that mediate lethal shock[J]. PlosBio,2011,19(9) :e100-149.
  • 7Saline M,Rodstrom KE,Fischer G,et al. The structure of superantigen complexed with TCR and MHC reveals novel insights into superanti- genic T cell activation[J]. Nat Commun ,2010,16( 1 ) : 119.
  • 8Tilahun ME,Kwan A,Natarajan K,et al. Chimeric anti-stgphy lococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB[J]. Plos One,2011,6 (11 ): 27203.
  • 9Kolb M, Fraser J.D,editors. Superantigens:rnolecular basis for their role in human diseases[M], book, 2008:2002-2003.
  • 10Mrowietz U,Reich K. Psoriasis-new insights into pathogenesis and treatment[J]. Deutsches rzteb|att international, 2009,106 ( 1-2 ) : 11-8.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部